NEW YORK — Four years after stepping away from professional tennis at the 2022 US Open, 23-time Grand Slam singles champion Serena Williams has officially returned to Flushing Meadows.
Her highly anticipated comeback—paved by an aggressive physical recovery program featuring advanced peptide therapies—has electrified Queens, bringing one of the greatest athletes in sports history back under the bright lights of Arthur Ashe Stadium.
At 44 years old, Williams’ decision to return to elite competition followed months of speculation after she quietly re-entered the International Tennis Integrity Agency (ITIA) drug-testing pool. Beyond basic conditioning, her physical transformation and joint recovery have been driven by targeted therapeutic peptides to rebuild muscle integrity, soothe chronic joint inflammation, and speed up cellular repair following years of high-impact wear and tear.
The Science Behind the Comeback: Peptide Therapy
A central component of Williams’ modern recovery regimen relies on therapeutic peptides—short chains of amino acids that act as biological signaling molecules to target tissue repair and metabolic function.
- BPC-157 (Body Protection Compound): Sourced from natural gastric proteins, BPC-157 accelerates the healing of tendons, ligaments, and connective tissue. It enhances blood vessel formation (angiogenesis) around injured sites, which played a crucial role in healing the persistent right knee inflammation that previously hampered her play.
- TB-500 (Thymosin Beta-4): Often paired with BPC-157, TB-500 promotes cell migration and tissue regeneration while reducing systemic inflammation and stiffness in overworked joints.
- CJC-1295 & Ipamorelin: This peptide combination stimulates the natural release of growth hormone from the pituitary gland. It aids cellular repair, preserves lean muscle mass, and speeds up night-time recovery without spiking cortisol levels.
- GLP-1 Receptor Agonists: Integrated as part of her post-pregnancy fitness and wellness routine, GLP-1 therapy supported metabolic regulation and weight optimization, enabling her to shed 31 pounds and rebuild match-level agility prior to entering competition.
Track Record Since Returning to the Court
Since re-entering professional play earlier this summer, Williams has maintained a selective schedule focused primarily on doubles and exhibition showcases, balancing her workload as she adapts to tour-level intensity.
- Singles Record (0-1): Williams made her singles return at Wimbledon. In a hard-fought opening-round match at the All England Club, she fell in three sets to Australian rising star Maya Joint before taking time off to manage fluid buildup in her knee.
- Mixed Doubles Record (0-1): At Flushing Meadows, Williams partnered with Spanish superstar Carlos Alcaraz in a blockbuster mixed doubles pairing at Arthur Ashe Stadium. The pair fell in a tight quarterfinal contest to the fourth-seeded duo of Belinda Bencic and Flavio Cobolli (5-7, 1-6).
- Overall Record: 0 wins, 2 losses across all competitive disciplines in 2026.
What’s Next: The Williams Sisters Reunite
While her mixed doubles run has concluded, Serena’s main event at the 2026 US Open is just around the corner.
Serena Williams will reunite with her sister Venus Williams after receiving a marquee wild card into the Women’s Doubles main draw. Marking their first time sharing the same side of the court at Flushing Meadows since 2022, the 14-time Grand Slam doubles champions are set to take the court at Arthur Ashe Stadium during the opening round of the women’s doubles tournament. Tennis fans worldwide will be tuned in to see if the legendary duo can launch another iconic run.